サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1392246

脳腫瘍診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測、2023年～2030年

Global Brain Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日
ページ情報
英文 248 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
脳腫瘍診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測、2023年～2030年
出版日: 2023年11月01日
発行: Value Market Research
ページ情報: 英文 248 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳腫瘍診断市場の世界需要は、2022年の25億米ドルから2030年には42億6,000万米ドル近くの市場規模に達すると推定され、調査期間2023年～2030年のCAGRは6.9%です。

脳腫瘍診断には、様々な医療処置、検査、画像技術による脳腫瘍やがんの同定、評価、判定が含まれます。これらの診断は、脳腫瘍を正確に診断し、その特徴、位置、大きさを決定し、がんの重症度を判定する上で極めて重要です。

市場力学：

脳腫瘍診断市場は、技術の進歩、疾病罹患率の上昇、ヘルスケアに対する意識の高まりなど、さまざまな要因に後押しされて成長しています。画像技術の進歩は、より正確で早期発見能力への需要を促進します。脳腫瘍の世界の有病率の増加は、早期発見とタイムリーな介入を促進するための正確な診断ツールと手技の必要性を高めています。認知度向上キャンペーンやスクリーニングの取り組みが、リスクのある集団における診断検査の需要をさらに押し上げています。生検技術や遺伝子検査における技術革新は、より正確な腫瘍の特徴付けに貢献し、個別化された治療アプローチに役立っています。さらに、非侵襲的診断法を好む傾向が、侵襲性の低い技術の開発を促進しています。政府支援、研究開発資金、診断企業とヘルスケア機関の協力は、技術革新と先進的な脳腫瘍診断ソリューションの開発を促進します。これらの要因が相まって、脳腫瘍診断市場の成長が促進され、早期発見とオーダーメイドの治療戦略のための、より効果的で患者に優しい診断ツールの創出が促進されます。

本調査レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、脳腫瘍診断の世界市場における各セグメントを包括的に評価することもできます。脳腫瘍診断産業の成長と動向は、本調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける脳腫瘍診断市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 脳腫瘍診断 - 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 脳腫瘍診断の世界市場分析：診断技術別

  • 診断技術別の概要
  • 実績データと予測データ
  • 診断技術別分析
  • 画像診断技術（磁気共鳴画像法（MRI）、コンピュータ断層撮影法（C1）スキャン、PETスキャンまたはPE CTスキャン、単光子放出コンピュータ断層撮影法（SPECT）スキャン）
  • 組織採取/生検
  • 分子診断
  • その他

第6章 脳腫瘍診断の世界市場分析：脳腫瘍タイプ別

  • 脳腫瘍タイプ別概要
  • 実績データと予測データ
  • 脳腫瘍タイプ別分析
  • 神経膠腫
  • 髄膜腫
  • 下垂体腫瘍
  • その他

第7章 脳腫瘍診断の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院
  • 診断研究所
  • がん病院／センター

第8章 脳腫瘍診断の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別売上分析
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 脳腫瘍診断企業の競合情勢

  • 脳腫瘍診断市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Thermo Fisher Scientific
  • Rare Diagnostics
  • Abbott Laboratories
  • Illumina Inc
  • Hologic Inc
  • Agilent Technologies
  • Bio Rad Laboratories
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Diagnostic Technique (USD MN)
  • Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Market Sales by Geography (USD MN)
  • Tissue Sampling/Biopsy Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Brain Cancer Type (USD MN)
  • Gliomas Market Sales by Geography (USD MN)
  • Meningiomas Market Sales by Geography (USD MN)
  • Pituitary Tumors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Cancer Hospitals/Centers Market Sales by Geography (USD MN)
  • Global Brain Cancer Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Brain Cancer Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Brain Cancer Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Diagnostic Technique
  • Market Attractiveness Analysis by Brain Cancer Type
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Diagnostic Technique (USD MN)
  • Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Market Sales by Geography (USD MN)
  • Tissue Sampling/Biopsy Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Brain Cancer Type (USD MN)
  • Gliomas Market Sales by Geography (USD MN)
  • Meningiomas Market Sales by Geography (USD MN)
  • Pituitary Tumors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Cancer Hospitals/Centers Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112878

The global demand for Brain Cancer Diagnostics Market is presumed to reach the market size of nearly USD 4.26 BN by 2030 from USD 2.5 BN in 2022 with a CAGR of 6.9% under the study period 2023 - 2030.

Brain cancer diagnostics involve the identification, assessment, and determination of brain tumors or cancers through various medical procedures, tests, and imaging techniques. These diagnostics are crucial in accurately diagnosing brain tumors, determining their characteristics, location, and size, and grading the cancer's severity.

MARKET DYNAMICS:

The brain cancer diagnostics market experiences growth propelled by diverse factors at the intersection of technological advancements, rising disease incidence, and healthcare awareness. Advancements in imaging technologies drive the demand for more precise and early detection capabilities. The increasing prevalence of brain tumors worldwide amplifies the need for accurate diagnostic tools and procedures to facilitate early detection and timely intervention. Heightened awareness campaigns and screening initiatives further drive the demand for diagnostic tests among at-risk populations. Technological innovations in biopsy techniques and genetic testing contribute to more precise tumor characterization, aiding in personalized treatment approaches. Moreover, the preference for non-invasive diagnostic methods fosters the development of less invasive techniques. Government support, research funding, and collaborations between diagnostic firms and healthcare institutions foster innovation and the development of advanced brain cancer diagnostic solutions. Collectively, these factors fuel the growth of the brain cancer diagnostics market, promoting the creation of more effective, patient-friendly diagnostic tools for early detection and tailored treatment strategies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of brain cancer diagnostics. The growth and trends of brain cancer diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the brain cancer diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnostic Technique

  • Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat)
  • Tissue Sampling/Biopsy
  • Molecular Diagnostics
  • Others

By Brain Cancer Type

  • Gliomas
  • Meningiomas
  • Pituitary Tumors
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Cancer Hospitals/Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Brain Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brain Cancer Diagnostics market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Rare Diagnostics, Abbott Laboratories, Illumina Inc, Hologic Inc, Agilent Technologies, Bio Rad Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BRAIN CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Diagnostic Technique
    • 3.7.2 Market Attractiveness Analysis By Brain Cancer Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC TECHNIQUE

  • 5.1 Overview by Diagnostic Technique
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Diagnostic Technique
  • 5.4 Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Historic and Forecast Sales by Regions
  • 5.5 Tissue Sampling/Biopsy Historic and Forecast Sales by Regions
  • 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY BRAIN CANCER TYPE

  • 6.1 Overview by Brain Cancer Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Brain Cancer Type
  • 6.4 Gliomas Historic and Forecast Sales by Regions
  • 6.5 Meningiomas Historic and Forecast Sales by Regions
  • 6.6 Pituitary Tumors Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 7.6 Cancer Hospitals/Centers Historic and Forecast Sales by Regions

8 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRAIN CANCER DIAGNOSTICS COMPANIES

  • 9.1. Brain Cancer Diagnostics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF BRAIN CANCER DIAGNOSTICS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. GE Healthcare
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Siemens Healthineers
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Philips Healthcare
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Thermo Fisher Scientific
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Rare Diagnostics
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Abbott Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Illumina Inc
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Hologic Inc
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Agilent Technologies
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Bio Rad Laboratories
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies